Systematic assessment of blood pressure (BP) control rates may help to improve the clinical management of hypertension in clinical practice. This approach had limited application in Europe over the last three decades and only recently has been implemented in some countries. The present study is aimed at evaluating hypertension prevalence and control among adult outpatients followed by a large, representative sample of general practitioners (GPs) in Italy. We retrospectively analysed the data derived from the GP Health Search-CSD database in 2013. Hypertension prevalence and control were estimated within the overall population sample and in hypertensive outpatients, respectively, according to age and gender. Hypertension diagnosis was defined according to the International Classification of Diseases 9. Clinic BP levels were measured according to the European guidelines. BP control was defined as systolic/diastolic BP <140/90 mm Hg. Data from 911 753 individuals (52.2% females) were scrutinized. Hypertension was diagnosed in 236 377 (25.9%) patients, being higher in male aged <70 years than age-matched female. Hypertension control was recorded in 60.6% of hypertensive patients, being higher in female than male individuals aged <70 years. Our current analysis demonstrates that about 26% of adult outpatients followed in the GP setting had hypertension and that about 61% had controlled BP levels. Both prevalence and control of hypertension appear to be higher when compared with the data reported from the analysis of the same database in 2005, thus confirming a positive trend in BP control in the GP clinical setting in Italy.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Whyte JL, Lapuerta P, L'Italien GJ, Franklin SS . The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988—-1994. J Clin Hypertens (Greenwich) 2001; 3 (4): 211–216.
Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43 (1): 10–17.
Bramlage P, Bohm M, Volpe M, Khan BV, Paar WD, Tebbe U et al. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich) 2010; 12 (9): 666–677.
Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB et al. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens 2011; 29 (8): 1641–1648.
Dallongeville J, Banegas JR, Tubach F, Guallar E, Borghi C, De Backer G et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol 2012; 19 (3): 541–550.
Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25 (7): 1491–1498.
Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A et al. Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012; 30 (6): 1065–1074.
Tocci G, Ferrucci A, Pontremoli R, Ferri C, Rosei EA, Morganti A et al. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys. J Hum Hypertens 2015; 29 (11): 696–701.
Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O . Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. J Hum Hypertens 2009; 23 (11): 758–763.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31 (7): 1281–1357.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311 (5): 507–520.
Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18 (3):139–185.
Volpe M . The changing role of hypertension societies: shifting gears in Italy. High Blood Press Cardiovasc Prev 2012; 19 (1): 1–2.
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288 (23): 2981–2997.
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348 (5): 383–393.
Mohan S, Campbell NR . Hypertension management: time to shift gears and scale up national efforts. Hypertension 2009; 53 (3): 450–451.
Campbell NR, Brant R, Johansen H, Walker RL, Wielgosz A, Onysko J et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009; 53 (2): 128–134.
Falaschetti E, Campbell NR, Mohan S, Poulter N . Implementation of pay for performance policy in England. Hypertension 2009; 54 (1): e5.
Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG . A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009; 53 (4): 646–653.
Mourad JJ, Girerd X . Objective for 2015: 70% of treated and controlled hypertensive patients. Seven key points to reach this goal in practice. A joint call for action of the French League against hypertension and the French Society of Hypertension. J Mal Vasc 2012; 37 (6): 295–299.
Filippi A, Bignamini AA, Sessa E, Samani F, Mazzaglia G . Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003; 34 (4):1010–1014.
Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003; 25 (3): 254–257.
Filippi A, Sangiorgi D, Buda S, Degli Esposti L, Nati G, Paolini I et al. How many hypertensive patients can be controlled in ‘real life’: an improvement strategy in primary care. BMC Fam Pract 2013; 14: 192.
Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011; 377 (9765): 568–577.
Filippi A, Degli Esposti L, Buda S, Diguardo A, Paolini I, Nati G . Why is my hypertensive patient still not controlled? High Blood Press Cardiovasc Prev 2015; 22 (1): 69–72.
Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R et al. [Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score]. Annali dell'Istituto superiore di sanita 2004; 40 (4): 393–399.
Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A et al. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med 2002; 162 (5): 582–586.
Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E Brisighella Heart Study Working Party. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens 2004; 22 (9): 1707–1716.
Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M . Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens 2005; 23 (8):1575–1581.
Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006; 332 (7542): 659–662.
Tocci G, De Luca N, Sarzani R, Ambrosioni E, Borghi C, Cottone S et al. National survey on excellence centers and reference centers for hypertension diagnosis and treatment: geographical distribution, medical facilities and diagnostic opportunities. High Blood Press Cardiovasc Prev 2014; 21 (1): 29–36.
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123 (8):933–944.
Unal B, Critchley JA, Capewell S . Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ 2005; 331 (7517): 614.
Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C et al. Renal artery denervation for treating resistant hypertension: definition of the disease, patient selection and description of the procedure. High Blood Press Cardiovasc Prev 2012; 19 (4): 237–244.
Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C et al. 2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev 2013; 20 (1): 45–52.
Volpe M, de la Sierra A, Kreutz R, Laurent S, Manolis AJ . ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients. High Blood Press Cardiovasc Prev 2014; 21 (2): 137–147.
Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005; 23 (12): 2269–2276.
Wall HK, Hannan JA, Wright JS . Patients with undiagnosed hypertension: hiding in plain sight. JAMA 2014; 312 (19): 1973–1974.
We thank Alessandro Filippi, MD, for his inspiring contribution to the analysis of the main findings of the present survey.
The authors declare no conflict of interest.
About this article
Cite this article
Tocci, G., Nati, G., Cricelli, C. et al. Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database. J Hum Hypertens 31, 258–262 (2017). https://doi.org/10.1038/jhh.2016.71
Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
Cardiovascular Research (2020)
High Blood Pressure & Cardiovascular Prevention (2020)
Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: the Feel4Diabetes-study
BMC Endocrine Disorders (2020)
Cardiometabolic risk prevention strategies: the importance of sharing experiences between Mediterranean countries
Internal and Emergency Medicine (2020)